North America Pharmaceutical Drug Delivery Market Segments and Growth by 2027
North America Pharmaceutical Drug Delivery Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Route of Administration (Oral Drug Delivery, Injectable Drug Delivery, Topical Drug Delivery, Ocular Drug Delivery, Pulmonary Drug Delivery, Nasal Drug Delivery, Transmucosal Drug Delivery, Implantable Drug Delivery); Application (Infectious Diseases, Cancer, Cardiovascular Diseases, Diabetes, Respiratory. Diseases, Central Nervous System Disorders, Autoimmune Diseases, and Other Diseases); End User (Hospitals, Home Care Settings, ASC/Clinics, Other End Users); and Country
- Status : Published
- Report Code : TIPRE00011595
- Category : Life Sciences
- No. of Pages : 145
- Available Report Formats :
- Last update date : June 15, 2020
2019 Market Size
US$ 560,491.5 Mn
Base year value
2027 Forecast
US$ 936,148.9 Mn
Projected by 2027
CAGR 2020-2027
6.8 %
Growth rate
Addressable Market
US$ 6,097,505.33 Mn
(2020-2027)
The North America pharmaceutical drug delivery market is anticipated to reach US$ 936,148.9 Mn by 2027 from US$ 560,491.5 Mn in 2019. The market is projected to grow at a CAGR of 6.8% during 2020–2027.
The growth of the market in this region is primarily ascribed to the increasing prevalence of chronic diseases. On the other hand, the high cost of developing drug delivery devices hinders the market growth. On the other hand, increasing spending in the R&D related to drug delivery devices is expected to fuel the growth of the North American pharmaceutical drug delivery market in the coming years. Pharmaceutical and medical devices companies are focusing on R&D to develop new molecules for various therapeutic applications and drug delivery platforms. They invest majorly on R&Ds with an aim to deliver high-quality and innovative products. R&D spending by the biopharmaceutical companies has also increased over the years. According to a report of Pharmaceutical Research and Manufacturers of America (PhRMA), the R&D expenditure of the biopharmaceutical companies increased from US$ 49.6 billion 2012 to US$ 58.8 billion in 2015. Evonik Corporation has invested more than US$ 50 million over the last 4 years to advance its competencies in the medical devices market as well as in the marketplace for RESOMER polymers for drug delivery and bioreabsorbable medical devices.
Additionally, the companies are engaged in establishing new collaborations and partnerships for the development of new drug delivery systems. For instance, in December 2018, IntelGenx Corp., a leading oral drug delivery company, entered into a strategic collaboration with Gensco Pharma for the commercialization of RIZAPORT in the US. The newly approved device would be the first oral thin film to be used in the treatment of migraines. In April 2020, Revive Therapeutics announced research partnership with the University of Wisconsin-Madison to develop novel formulations and drug delivery technologies.
In 2019, the US accounted for the largest share in North America pharmaceutical drug delivery market, and it is also expected to grow at a faster pace over the forecast period. The US is an economically advanced country, and it leverages the presence of various well-established pharmaceutical market players. Increasing prevalence of chronic diseases such as diabetes and asthma, growing number of product launches by key players, and increasing use of drug delivery devices for disease management are among the key factors driving the country toward the largest market share.
US Pharmaceutical Drug Delivery Market, Revenue and Forecast to 2027 (US$ Mn)
- This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
NORTH AMERICA PHARMACEUTICAL DRUG DELIVERY MARKET SEGMENTATION
By Route of Administration
- Oral Drug Delivery
- Injectable Drug Delivery
- Topical Drug Delivery
- Ocular Drug Delivery
- Pulmonary Drug Delivery
- Nasal Drug Delivery
- Transmucosal Drug Delivery
- Implantable Drug Delivery
By Application
- Infectious Diseases
- Cancer
- Cardiovascular Diseases
- Diabetes
- Respiratory Diseases
- Central Nervous System Disorders
- Autoimmune Diseases
- Other Applications
By End User
- Hospitals
- Home Care Settings
- ASC/Clinics
- Other End Users
By Country
- North America
-
- US
- Canada
- Mexico
Company Profiles
- 3M
- Antares Pharma
- BD
- Pfizer Inc.
- Johnson & Johnson Services, Inc.
North America Pharmaceutical Drug Delivery Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2019 | US$ 560,491.5 Million |
| Market Size by 2027 | US$ 936,148.9 Million |
| CAGR (2020 - 2027) | 6.8% |
| Historical Data | 2017-2018 |
| Forecast period | 2020-2027 |
| Segments Covered |
By Route of Administration
|
| Regions and Countries Covered |
North America
|
| Market leaders and key company profiles |
|
- Comprehensive Market Sizing and Forecast Analysis
- Detailed Segmentation Analysis
- In-Depth Market Dynamics Assessment
- Regional and Country-Level Insights
- Competitive Landscape and Company Benchmarking
- Strategic Business Intelligence
Recent Reports
Testimonials
The Insight Partners provided valuable market intelligence that supported our global go-to-market strategy. Their team was professional, responsive, and attentive to our feedback, providing thoughtful analysis and helpful methodological clarifications throughout the project.
Junmo Kim Chief Financial Officer (CFO), Enertech Co., Ltd.
The Insight Partners' SCADA System Market report is comprehensive, with valuable insights on current trends and future forecasts. The team was highly professional, responsive, and supportive throughout. We are very satisfied and highly recommend their services.
RAN KEDEM Partner, Reali Technologies LTDs
I requested a report on a very specific software market and the team produced the report in a few days. The information was very relevant and well presented. I then requested some changes and additions to the report. The team was again very responsive and I got the final report in less than a week.
JEAN-HERVE JENN Chairman, Future Analytica
We worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.
PIYUSH NAGPAL Sr. Vice President, High Beam Global
The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services
YUKIHIKO ADACHI CEO, Deep Blue, LLC.
This is the first time I have purchased a market report from The Insight Partners.While I was unsure at first, I visited their web site and felt more comfortable to take the risk and purchase a market report.I am completely satisfied with the quality of the report and customer service. I had several questions and comments with the initial report, but after a couple of dialogs over email with their analyst I believe I have a report that I can use as input to our strategic planning process.Thank you so much for taking the extra time and making this a positive experience.I will definitely recommend your service to others and you will be my first call when we need further market data.
JOHN SUZUKI President and Chief Executive Officer, Board Director, BK Technologies
I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.
DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Get Free Sample for